HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Feels Heat Alongside J&J As House Oversight Investigates OTC Recall

This article was originally published in The Tan Sheet

Executive Summary

FDA finds itself under congressional scrutiny alongside Johnson & Johnson even as the agency investigates and weighs possible enforcement against J&J following the firm's third OTC recall in eight months

You may also be interested in...

FDA To Toughen OTC Oversight, Seek New Authority In Wake Of J&J Recalls

FDA will monitor more closely OTC manufacturing operations and require comprehensive changes at firms with systemic quality deficiencies as a result of its investigation of Johnson & Johnson's McNeil Consumer Healthcare

McNeil Elevates Quality Management In Wake Of Tylenol, Motrin Recall

McNeil Consumer Healthcare adds executive posts for quality assurance in its response to FDA's warning about a problem with packaging materials that led to a massive recall of OTC products

New House Oversight Panel Chairman Towns Less Combative With Industry

Drug companies likely will face less combative investigations into their activities by the House Oversight and Government Reform Committee during the 111th Congress





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts